|
Patient-Derived Xenografts to Reduce Cancer Health Disparities
RECRUITINGSponsored by University of California, Davis
Actively Recruiting
SponsorUniversity of California, Davis
Started2019-11-12
Est. completion2026-12
Eligibility
Age21 Years – 100 Years
Healthy vol.Accepted
Locations2 sites
View on ClinicalTrials.gov →
NCT04410302
Summary
This trial establishes patient-derived cancer xenografts in addressing cancer health and treatment disparities that disproportionately affect racial/ethnic minorities. Understanding the genetic and response differences among racial/ethnic minorities may help researchers enhance the precision of therapeutic treatments.
Eligibility
Age: 21 Years – 100 YearsHealthy volunteers accepted
Inclusion Criteria: * Patient receiving treatment for the above 4 cancers (bladder cancer, lung cancer, gastric/stomach cancer, and liver cancer) * Signed informed consent that will be put on file Exclusion Criteria: * No informed consent obtained * Specimen unacceptable/degraded/etc. * Individuals who are not yet adults (infants, children, teenagers) * Pregnant women * Prisoners * Adults unable to consent
Conditions9
Bladder CarcinomaCancerGastric CarcinomaLiver CancerLiver DiseaseLiver and Intrahepatic Bile Duct CarcinomaLung CancerLung CarcinomaMalignant Neoplasm
Locations2 sites
UC Irvine Health/Chao Family Comprehensive Cancer Center
University of California Davis Comprehensive Cancer Center
Find trials near these locations
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorUniversity of California, Davis
Started2019-11-12
Est. completion2026-12
Eligibility
Age21 Years – 100 Years
Healthy vol.Accepted
Locations2 sites
View on ClinicalTrials.gov →
NCT04410302